Nautilus Biotechnology, Inc. (NAUT) Tops Q2 EPS by 2c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q2 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15